Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ILF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TSPAN14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM38B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAWR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC125 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBTF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARPC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRSF7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBC1D1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAP1L4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DHPS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VARS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AVL9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AAMP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NADSYN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DSCR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATG101 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SART1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on